SEARCH WITHIN CONTENT
VOLUME 30 , ISSUE 4 ( October-December, 2019 ) > List of Articles
Ashish Srivastava, Sanjay Kumar Pandey, Anjani Kumar, Amit K Mallik, Swati Sinha
Keywords : Triamcinolone, Zygapophyseal joint,Hyaluronic acid
Citation Information : Srivastava A, Pandey SK, Kumar A, Mallik AK, Sinha S. Effect of Intra-articular Triamcinolone vs Hyaluronate Injection in Zygapophyseal Joint Arthropathy: A Prospective Randomized Controlled Trial. Indian J Phy Med Rehab 2019; 30 (4):101-104.
License: CC BY-NC 4.0
Published Online: 02-11-2020
Copyright Statement: Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.
Objective: To compare the effect of triamcinolone with hyaluronate injection in low back pain due to zygapophyseal joint arthropathy. Materials and methods: This was a prospective, single-blind, randomized controlled trial. Twenty-nine subjects were randomly assigned to receive bilateral L3-S1 zygapophyseal joint injections with triamcinolone or hyaluronate (HA). Pain (visual analog scale) and disability (Oswestry Disability Index, ODI) scores were evaluated at 1, 4, and 12 weeks. Results: No significant intergroup differences in outcomes were noted in 29 subjects. For triamcinolone/HA (baseline; 1 month; 3 months; and 6 months), visual analog scales were as follows: 77.07/76.14; 62.93/63.71; 43.47/43.14; and 44.27/59.57, respectively. ODI scores were as follows: 52.53/52.71; 37.60/37.14; 23.73/23.71; and 41.07/50.57, respectively. Conclusion: The response of patients with chronic low back pain suggestive of lumbar zygapophyseal joint arthropathy was almost similar to triamcinolone or hyaluronate injection. Triamcinolone showed both short- and long-term improvement in both short- and long-term pain and function.
© Jaypee Brothers Medical Publishers (P) LTD.